Intellia Therapeutics, Inc. $NTLA Stock Purchased by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. boosted its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 24.4% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 3,605,623 shares of the company’s stock after purchasing an additional 708,094 shares during the period. Sumitomo Mitsui Trust Group Inc. […]
5 Nov 05:44 · The Cerbat Gem